| Tender Details | ||||||||
|
||||||||
| Deadline * | ||||||||
|
||||||||
| Client Address | ||||||||
|
||||||||
| More Information | ||||||||
| Know More | ||||||||
Similar Tenders
- Ref No: 8259327
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1
- Deadline: 10 May 2026
- Ref No: 8260726
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg
- Deadline: 10 May 2026
- Ref No: 3695236
- Location: United States
Proctor Care And Independent Living Services
- Deadline: 30 Nov 2027
- Ref No: 5301821
- Location: Bulgaria
Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad
- Deadline: 27 May 2027
- Ref No: 5396790
- Location: Germany
Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L
- Deadline: 27 Apr 2026
- Ref No: 4608627
- Location: Canada
Concussion And Vestibular Physiotherapy Services
- Deadline: 18 Mar 2026
- Ref No: 4641976
- Location: Germany
Medicines With The Active Ingredient Combination Oxycodone And Naloxone Atc N02Aa55
- Deadline: 28 Feb 2026
- Ref No: 4638957
- Location: Germany
Medicines With The Active Ingredient Tacrolimus Atc L04Ad02
- Deadline: 28 Feb 2026
- Ref No: 6670434
- Location: France
Supply And Delivery Of New Electric And Hybrid Vehicles With Associated Services For The Accm Urban Community
- Deadline: 27 Jun 2028
- Ref No: 5226107
- Location: Germany
Medicines With The Active Ingredient Combination Vilanterol Umeclidinium Bromide And Fluticasone Furoate Atc R03Al08
- Deadline: 31 Mar 2026
- Ref No: 5976401
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf
- Deadline: 10 May 2026
